Novartis Denied Summary Judgment in Illinois Zometa ONJ Case



DOCUMENTS
  • Order


EAST ST. LOUIS, Ill. — An Illinois federal judge has denied Novartis Pharmaceuticals Corp. (NYSE: NVS) summary judgment in a Zometa injury action, finding issues of material fact with respect to causation and adequacy of warnings.

On Dec. 17, Judge Michael Reagan of the U.S. District Court for the Southern District of Illinois found the plaintiff presented adequate evidence that Zometa caused his late mother to contract bisphosphonate-related osteonecrosis of the jaw and that Novartis knew its warnings were inadequate.

Christopher Rutz alleges that his late mother, Carolyn, developed osteonecrosis of the jaw as a result of Zometa infusions prescribed …

FIRM NAMES
  • Flynn & Radford
  • Foley & Mansfield
  • Hollingsworth
  • Pittman Germany Roberts & Welsh
  • Spencer Fane Britt & Browne





UPCOMING CONFERENCES




HarrisMartin's New Jersey Asbestos Litigation Conference

March 03, 2023 - New Brunswick, NJ
Hyatt Regency New Brunswick

MORE DETAILS



HarrisMartin's MDL Conference: Managing Mass Torts, Status of Key Litigations and Lessons Learned

March 29, 2023 - Tucson, AZ
Hotel Details in Tucson, Arizona, to be Announced

MORE DETAILS